[Morphological study on the gastric mucosa in diabetes mellitus rats induced by streptozotocin]

T Watanabe1, A Asanuma, M Tanaka

  • 1Fuji Research Laboratories, Kowa Co., Ltd., Shizuoka, Japan.

Experimental Animals
|October 1, 1995
PubMed

Insights

Diabetes mellitus (DM) increases susceptibility to acute gastric mucosal lesions (AGML). In DM rats, a thinner surface epithelial cell (SEC) layer and reduced cell proliferation impair the gastric mucosal barrier, contributing to AGML.

Area of Science:

  • Gastroenterology
  • Endocrinology
  • Pathology

Context:

  • Diabetes mellitus (DM) is associated with an increased risk of gastrointestinal complications.
  • Acute gastric mucosal lesions (AGML) are a potential complication in diabetic patients.
  • The specific mechanisms underlying this vulnerability remain incompletely understood.

Purpose:

  • To elucidate the histopathological basis of increased susceptibility to acute gastric mucosal lesions (AGML) in the context of diabetes mellitus (DM).
  • To investigate alterations in the gastric mucosa of the fundic gland in streptozotocin-induced diabetic rats.

Summary:

  • Histopathological analysis of gastric mucosa in diabetic rats revealed a decreased ratio of the surface epithelial cell (SEC) layer length to the overall mucosal length.
  • A significant reduction in the number of proliferating cell nuclear antigen (PCNA)-positive cells was observed in diabetic rats compared to controls.
  • These findings suggest that impaired SEC layer integrity and reduced cell proliferation contribute to a weakened gastric mucosal barrier in DM.

Impact:

  • This study highlights the compromised gastric mucosal barrier in diabetes as a key factor in AGML pathogenesis.
  • Understanding these mechanisms can inform the development of targeted therapeutic strategies for preventing gastric lesions in diabetic individuals.
  • The research provides a histopathological basis for the gastrointestinal manifestations observed in diabetes mellitus.

Related Concept Videos